SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-006365
Filing Date
2024-03-04
Accepted
2024-03-04 08:24:09
Documents
17
Period of Report
2024-03-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240303_8k.htm   iXBRL 8-K 33491
2 EXHIBIT 99.1 ex_633977.htm EX-99.1 15446
7 picture3.jpg GRAPHIC 5788
  Complete submission text file 0001437749-24-006365.txt   193100

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240304.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240304_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240304_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240304_pre.xml EX-101.PRE 12022
18 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240303_8k_htm.xml XML 2948
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 24712934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)